Comparison of outcomes with utilization of hyperthermic intraperitoneal chemotherapy with paclitaxel and cisplatin versus cisplatin alone at interval debulking surgery in women with epithelial ovarian cancer

Debulking Surgery ◽

Interval Debulking Surgery

Anastomotic leak following interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in women with advanced epithelial ovarian Cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2021.06.034 ◽

2021 ◽

Author(s):

Morgan Gruner ◽

Laura M. Chambers ◽

Meng Yao ◽

Anna Chichura ◽

Molly Morton ◽

...

Keyword(s):

Ovarian Cancer ◽

Anastomotic Leak ◽

Debulking Surgery ◽

Cisplatin and paclitaxel are associated with improved progression-free survival compared to cisplatin alone during interval debulking surgery with hyperthermic intraperitoneal chemotherapy in women with advanced epithelial ovarian cancer

Gynecologic Oncology ◽

10.1016/s0090-8258(21)00754-x ◽

2021 ◽

Vol 162 ◽

pp. S58-S59

Author(s):

Laura Chambers ◽

Max Horowitz ◽

Anthony Costales ◽

Meng Yao ◽

Anna Chichura ◽

...

Keyword(s):

Ovarian Cancer ◽

Progression Free Survival ◽

Debulking Surgery ◽

Free Survival ◽

Hyperthermic intraperitoneal chemotherapy in interval debulking surgery for advanced epithelial ovarian cancer: A single‐center, real‐life experience

Cancer ◽

10.1002/cncr.33167 ◽

2020 ◽

Vol 126 (24) ◽

pp. 5256-5262 ◽

Cited By ~ 2

Author(s):

Valentina Ghirardi ◽

Carlo Ronsini ◽

Rita Trozzi ◽

Chiara Di Ilio ◽

Andrea Di Giorgio ◽

...

Keyword(s):

Ovarian Cancer ◽

Life Experience ◽

Real Life ◽

Single Center ◽

Debulking Surgery ◽

Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study

Journal of Gynecologic Oncology ◽

10.3802/jgo.2019.30.e3 ◽

2019 ◽

Vol 30 (1) ◽

Cited By ~ 9

Author(s):

Yong Jae Lee ◽

Jung-Yun Lee ◽

Min-Soo Cho ◽

Eun Ji Nam ◽

Sang Wun Kim ◽

...

Keyword(s):

Ovarian Cancer ◽

Pilot Study ◽

Neoadjuvant Chemotherapy ◽

Advanced Stage ◽

Debulking Surgery ◽

Interval Debulking Surgery

Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2020.09.052 ◽

2021 ◽

Vol 160 (1) ◽

pp. 45-50

Author(s):

Molly Morton ◽

Laura M. Chambers ◽

Anthony B. Costales ◽

Anna Chichura ◽

Morgan Gruner ◽

...

Keyword(s):

Ovarian Cancer ◽

Minimally Invasive Surgery ◽

Minimally Invasive ◽

Invasive Surgery ◽

Perioperative Outcomes ◽

Debulking Surgery ◽

Hyperthermic intraperitoneal chemotherapy (HIPEC) after primary debulking surgery in advanced epithelial ovarian cancer: Is BRCA mutational status making the difference?

Cancer Treatment and Research Communications ◽

10.1016/j.ctarc.2022.100518 ◽

2022 ◽

pp. 100518

Author(s):

Valentina Ghirardi ◽

Francesca De Felice ◽

Marco D'Indinosante ◽

Federica Bernardini ◽

Maria Teresa Giudice ◽

...

Keyword(s):

Ovarian Cancer ◽

Debulking Surgery ◽

Primary Debulking Surgery ◽

Mutational Status ◽

Advanced Epithelial Ovarian Cancer ◽

The Difference

EPV226/#634 Hyperthermic intraperitoneal chemotherapy with CO2 recirculation system (PRS) after interval debulking surgery in advanced ovarian cancer (AOC): preliminary efficacy results from a phase II study

10.1136/ijgc-2021-igcs.297 ◽

2021 ◽

Author(s):

F Murgia ◽

V Carone ◽

L Leone ◽

V Caroli Casavola ◽

A Cristofano ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Ovarian Cancer ◽

Debulking Surgery ◽

Recirculation System

Abstract NTOC-096: INTRAPERITONEAL CHEMOTHERAPY AFTER PRIMARY OR INTERVAL DEBULKING SURGERY FOR ADVANCED EPITHELIAL OVARIAN CANCER

10.1158/1557-3265.ovcasymp16-ntoc-096 ◽

2017 ◽

Author(s):

Jessica Lee ◽

John P Curtin ◽

Franco M Muggia ◽

Bhavana Pothuri ◽

Leslie R. Boyd ◽

...

Keyword(s):

Ovarian Cancer ◽

Debulking Surgery ◽

Hyperthermic intraperitoneal chemotherapy after secondary cytoreduction in epithelial ovarian cancer: A single-center experience

10.26226/morressier.5770e29dd462b80290b4c19d ◽

2016 ◽

Author(s):

yeliz aykanat

Keyword(s):

Ovarian Cancer ◽

Single Center ◽

Single Center Experience

Faculty of 1000 evaluation for Phase II study of interval debulking surgery followed by intraperitoneal chemotherapy for advanced ovarian cancer: A Kansai Clinical Oncology Group study (KCOG9812).

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717962364.793467463 ◽

2012 ◽

Author(s):

Steve Plaxe ◽

Kristy Ward

Keyword(s):

Ovarian Cancer ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Ovarian Cancer ◽

Oncology Group ◽

Debulking Surgery ◽

Oncology Group Study ◽

Interval Debulking Surgery